Neuroplast
Series BNeuroplast raised €10M in a Series B round in Nov 2021. The company is based in Geleen, Netherlands. Investors in the round: Brightlands Venture Partners, Lumana Invest, Netherlands Enterprise Agency and 1 other. Data as of Nov 2026.
Amount raised
€10M
€10,000,000
Native amount
10,000,000 EUR
Stage
Series B
series b
Investors
4
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €10M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
4 namedDate
Nov 2021
Round type
series b
Amount (EUR)
€10M
Other rounds
same companyRelated news
- Dutch biotech startup Neuroplast raises €10M to help treat Traumatic Spinal Cord Injury; here’s howsiliconcanals.com · 2021-11